https://brainchildbio.com/press-release/seattle-childrens-launches-brainchild-bio-to-accelerate-car-t-cell-therapies-for-children-with-brain-tumors/ 2026-09-24T17:52:21+00:00 https://brainchildbio.com/press-release/fda-grants-breakthrough-therapy-designation-for-brainchild-bios-b7-h3-car-t-cell-therapy-for-incurable-pediatric-brain-tumors/ 2026-09-24T21:42:44+00:00 https://brainchildbio.com/press-release/fda-grants-regenerative-medicine-advanced-therapy-designation-for-brainchild-bios-b7-h3-car-t-cell-therapy-for-incurable-pediatric-brain-tumors/ 2026-09-24T21:50:47+00:00 https://brainchildbio.com/press-release/brainchild-bio-initiates-pivotal-phase-2-trial-for-bcb-276-car-t-cell-therapy-for-dipg-a-deadly-pediatric-brain-cancer/ 2026-09-24T22:00:02+00:00 https://brainchildbio.com/press-release/brainchild-bio-closes-116-million-series-a-financing/ 2026-09-24T22:06:56+00:00 https://brainchildbio.com/press-release/brainchild-bio-inc-to-clinically-advance-bcb-276-an-autologous-b7-h3-targeting-car-t-cell-therapy-for-incurable-pediatric-brain-tumors/ 2026-09-25T15:16:41+00:00